Company Directory > Digital Health > Katana Labs GmbH
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Katana Labs GmbH and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Katana Labs is a German TechBio startup founded in 2023 that specializes in AI-powered software for spatial biology and digital pathology. The company's flagship platform, Katana Edge, is a cloud-native solution designed to automate the analysis of complex tissue imaging and multi-omics data, helping R&D teams in biopharma and clinical research accelerate biomarker discovery and precision medicine workflows. By leveraging deep learning and agentic AI, Katana Labs aims to bridge the gap between massive, multidimensional datasets and actionable biological insights. The company operates as a hardware-agnostic partner, providing both software platforms and specialized data analytics services to support translational research and drug development.
CLASSIFICATION
Company Type:Digital Health
Therapeutic Areas:
Industry:Biotechnology
Sub-Industry:Digital Health / AI in Drug Discovery
SIZE & FINANCIALS
Employees:1-50
Founded:2023
Ownership:private
Status:operating
FUNDING
Stage:Seed
Investors:Technologiegründerfonds Sachsen (TGFS)
PIPELINE
Stage:Commercial
Lead Drug Stage:N/A (Software/Services)
Modalities:Spatial Omics, Digital Pathology
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Key Partnerships:Lumito AB (Strategic partnership to commercialize an end-to-end IHC workflow)
COMPETITION
Position:Emerging
LEADERSHIP
Key Executives:
Norman Gerstner - CEO
Falk Zakrzewski - Co-founder & Head of Strategy
Walter de Back - Co-founder & CTO
Nicolaus Widera - Co-founder & Head of Operations
Scientific Founders:Falk Zakrzewski, Walter de Back, Nicolaus Widera
LINKS
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Katana Labs GmbH. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.